Validation Study of a New Random-Access Chemiluminescence Immunoassay Analyzer I-Track10® to Monitor Infliximab and Adalimumab Serum Trough Levels and Anti-Drug Antibodies
International Journal of Molecular Sciences（2022）
Key words
TNF inhibitors,adalimumab,infliximab,therapeutic drug monitoring,anti-drug antibodies,CLIA,ELISA
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined